Amgen Inc. (4332.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
As of 09:20AM HKT. Market open.
| Previous close | 1,850.000 |
| Open | 1,761.000 |
| Bid | 1,761.000 x N/A |
| Ask | 0.000 x N/A |
| Day's range | 1,761.000 - 1,761.000 |
| 52-week range | 1,761.000 - 1,850.000 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 1.089T |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 16.03 |
| EPS (TTM) | 109.890 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | 66.66 (3.60%) |
| Ex-dividend date | 16 Nov 2023 |
| 1y target est | 248.18 |
PR NewswireAMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:20 a.m. PT on Tuesday, May 14, 2024. Peter Griffith, executive vice president and chief financial officer at Amgen, and Jay Bradner, executive vice president of Research and Development and chief scientific officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the genera
Simply Wall St.Amgen First Quarter 2024 Earnings: EPS Misses Expectations
Amgen ( NASDAQ:AMGN ) First Quarter 2024 Results Key Financial Results Revenue: US$7.45b (up 22% from 1Q 2023). Net...
Yahoo FinanceAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
© 2024 Yahoo. All rights reserved.